10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

10x Genomics Inc.

The latest announcement is out from Addentax Group ( ($ATXG) ). On May 15, 2026, Addentax Group Corp. agreed a related-party share exchange in whic...

Addentax Group Announces Related-Party Share Exchange Agreement

Terex Corporation (($TEX)) has held its Q1 earnings call. Read on for the main highlights of the call. Terex Corporation’s latest earnings call str...

Terex Corporation Earnings Call Signals Resilient Growth

Addentax Group ( ($ATXG) ) has shared an announcement. On May 15, 2026, Addentax Group completed a share exchange transaction under an April 22, 20...

Addentax Group Completes Share-Based Acquisition of Subsidiary

Torex Gold (($TSE:TXG)) has held its Q1 earnings call. Read on for the main highlights of the call. Torex Gold’s latest earnings call struck an opt...

Torex Gold Earnings Call Highlights Cash-Fueled Momentum

In a report released today, Kyle Mikson CFA from Canaccord Genuity reiterated a Buy rating on 10x Genomics, with a price target of $32.00. Accordin...

10x Genomics (TXG) Gets a Buy from Canaccord Genuity

Barclays analyst Luke Sergott maintained a Buy rating on 10x Genomics today and set a price target of $30.00. According to TipRanks, Sergott is an ...

10x Genomics (TXG) Receives a Buy from Barclays

In a report released yesterday, Michael Ryskin from Bank of America Securities reiterated a Hold rating on 10x Genomics, with a price target of $30...

Bank of America Securities Keeps Their Hold Rating on 10x Genomics (TXG)

Terex ( ($TEX) ) just unveiled an announcement. On May 1, 2026, Terex reported first-quarter 2026 net sales of $1.7 billion, up 41% year over year ...

Terex Reports Strong Q1 2026 Sales, Reaffirms Outlook

Addentax Group ( ($ATXG) ) has provided an update. On April 22, 2026, Addentax Group Corp. agreed a share exchange under which its Hong Kong subsid...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TXG	$24.62	+3.97%	1.97M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TXG	$24.62	+4.0%	1.97M
3
4
5
6

TXG

TXG

Get 10x Genomics Inc. Data in Excel

Get 10x Genomics Inc. Data in Excel